Congressional Trader
Live

CCL congressional trades

7 matched disclosures

Track congressional trades for CCL
Tracked disclosures
7
Lawmakers
4
Buy / sell
4 / 3
Avg post-trade move
N/A
Latest filing 2025-11-18

CCL congressional trades snapshot

This page summarizes public STOCK Act disclosures involving CCL. It is useful for seeing which lawmakers reported CCL transactions, how many filings are visible, the buy/sell mix, and whether the newest public filing describes a recent or delayed trade.

Last updated

Nov 18, 2025

Data source

Public House and Senate STOCK Act disclosures normalized by Congressional Trader.

Key caveat

Filing date can trail transaction date. This page is for research and monitoring, not investment advice.

What the CCL congressional trade page shows

Congressional Trader tracks 7 public STOCK Act disclosures for CCLacross 4 lawmakers. This page separates purchases from sales, shows filing delays, and links each disclosure back to the individual politician profile when available.

The most recent CCL filing shown here was filed on Nov 18, 2025 by Byron Donalds as a purchase. Related lawmakers include Jefferson Shreve, Byron Donalds, Susie Lee, Tommy Tuberville.

Pro performance summary

Unlock 30/90-day post-trade summaries, committee overlap, and CSV-oriented research views for high-intent ticker research.

Compare Pro plans
Byron DonaldsR-FLHouse
No committee data
Filed Nov 18, 2025
Delay 40 days
View filing
CCLNotable
Carnival Corporation Common Stock
Purchase
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
Byron DonaldsR-FLHouse
No committee data
Filed Nov 18, 2025
Delay 40 days
View filing
Carnival Corporation Common Stock
Purchase
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
No committee data
Filed Jun 22, 2025
Delay 41 days
View filing
Carnival Corporation Common Stock
Sale
$15K - $50K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
No committee data
Filed Jun 22, 2025
Delay 45 days
View filing
CCLNotable
Carnival Corporation Common Stock
Purchase
$15K - $50K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
No committee data
Filed May 8, 2025
Delay 31 days
View filing
CCLNotable
Carnival Corporation Common Stock
Sale
$15K - $50K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
Susie LeeD-NVHouse
No committee data
Filed Apr 11, 2025
Delay 28 days
View filing
CCLNotable
Carnival Corporation Common Stock
Sale
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
No committee data
Filed May 15, 2024
Delay 16 days
View filing
CCLNotable
Carnival Corporation Common StockOption Type: PutStrike price:$17.50Expires:06/21/2024
Purchase
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade

FAQ

Which lawmakers traded CCL?

Recent CCL disclosures include Jefferson Shreve, Byron Donalds, Susie Lee, Tommy Tuberville.

What is the buy/sell mix for CCL?

The visible sample currently shows 4 purchases and 3 sales or partial sales.

Should I trade based on CCL disclosures?

No. This page summarizes public filings for research and monitoring. It is not investment advice.